Therapeutic agent for digestive tract diseases

Details Therapeutic agent for digestive tract diseases Therapeutic agent for digestive tract diseases

1994-02-09

1995-07-11

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530324, C07K 734, A61K 3826

Patent

active

054321565

ABSTRACT:
Therapeutic agents for the digestive tract diseases which comprise glicentin as active ingredients.

REFERENCES:
Nature 304, Graeme I. Bell, et al., "Exon duplication and divergence in the human preproglucagon gene", pp. 368-371, 1983.
Br.J.Surg. vol.69, G. R. Sagor, et al., "The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat", pp. 14-18, 1982.
Gut 12, M. H. Gleeson, et al., "Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function", pp. 773-782, Jul. 27, 1971.
Gut, 13, S. R. Bloom, "An enteroglucagon tumour", pp. 520-523, Apr. 27, 1972.
Peptide, 3, L. O. Uttenthal, et al., "Stimulation of DNA Synthesis in Cultured Small Intestine By Partially Enteroglucagon", p. 84, 1982.

Affiliated with

Also associated with

Rating

Therapeutic agent for digestive tract diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for digestive tract diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for digestive tract diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503494